GlassScriptPhysician profile
Sitaramesh Emani
NPI 1114942752
$87,347.31
in general payments reported to CMS, 2019-2025
28 companies · $35K in 2025
The $35K reported for 2025 was more than what 90% of Advanced Heart Failure and Transplant Cardiology providers received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $13K · 2021: $2,530 · 2022: $5,006 · 2023: $1,982 · 2024: $16K · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $32K · Travel and Lodging: $8,050 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,382 · Food and Beverage: $5,759.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $31,501.00 |
| Travel and Lodging | $8,050.41 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,382.00 |
| Food and Beverage | $5,759.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $20,292.22 | 2021-2025 | General - Structural Heart, Avvigo Guidance System |
| Zoll Respicardia, INC. | $18,304.99 | 2019-2021 | |
| Nuwellis, INC. | $15,762.05 | 2019-2025 | Aquadex Smartflow Console |
| Bayer Healthcare Pharmaceuticals INC. | $12,341.62 | 2021-2025 | |
| Abbott Laboratories | $10,404.67 | 2019-2025 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Cvrx, INC. | $3,242.87 | 2023-2025 | Barostim Neo System |
| Abiomed | $2,025.06 | 2019-2025 | Impella |
| Medtronic Vascular, INC. | $1,399.85 | 2019 | |
| Vifor Pharma, INC. | $1,048.07 | 2020 | |
| Medtronic, INC. | $841.06 | 2023-2025 | Reveal Linq, Linq II |
| Angiodynamics, INC. | $493.19 | 2022 | |
| Novartis Pharmaceuticals Corporation | $395.92 | 2024-2025 | |
| Briohealth Solutions, INC. | $148.49 | 2025 | Briovad |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $119.59 | 2023-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $82.16 | 2025 | Camzyos |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $77.04 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $65.33 | 2024-2025 | Verquvo |
| Edwards Lifesciences Corporation | $59.83 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $48.66 | 2024 | Wainua, Andexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.07 | 2024 | Jardiance |
| Ancora Heart, INC. | $36.64 | 2025 | Accucinch |
| Alnylam Pharmaceuticals INC. | $28.15 | 2025 | Onpattro |
| Endotronix, INC. | $22.67 | 2024 | Cordella Pulomonary Artery Pressure Sensor |
| Atricure, INC. | $18.69 | 2025 | Atriclip Laa Exclusion System |
| Novo Nordisk INC | $15.66 | 2024 | Rybelsus, Ozempic |
| Pfizer INC. | $14.71 | 2024 | |
| Biotronik INC. | $13.05 | 2023 | Trapit, Recross, Pk Papyrus |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sitaramesh Emani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.